封面
市場調查報告書
商品編碼
2051170

合成生物學市場:按產品、技術、最終用戶和地區分類

Synthetic Biology Market, By Product, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,合成生物學市場規模將達到268.7億美元,到2033年將達到1,125.1億美元。預計從2026年到2033年,該市場將以22.7%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 268.7億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 22.70% 2033年市場規模預測: 1125.1億美元

合成生物學是一門新興領域,它將工程學原理應用於生物學。這包括設計和建造新型人工生物路徑、生物體或裝置,以及重新設計現有的天然生物系統。合成生物學的關鍵應用包括開發用於燃料、化學品和材料的先進生物製造技術,以及開發用於農業、製藥和環境解決方案的基因改造生物。研究人員正致力於開發基因改造生物系統,以實現更有效率、更環保的生產過程。 DNA定序、基因組裝和編輯技術的進步正在推動該領域的快速發展,並有望解決醫療保健、能源和環境領域許多緊迫的全球性挑戰。

市場動態

全球合成生物學市場的發展受到許多因素的驅動,例如研發投入和投資的增加、DNA定序和基因編輯技術的進步、生物製藥需求的成長以及代謝工程等領域的技術發展。行業標準正在製定中,以確保合成生物學的負責任和安全應用。然而,與基因改造生物相關的監管問題和倫理擔憂可能會阻礙市場成長。合成生物學為解決藥物發現、工業生物製造和環境修復等多個領域的挑戰提供了機會。商業應用的發展、國際合作以及DNA合成和基因組工程成本效益的提高將促進市場擴張。

本次調查的主要特點

  • 本研究確定了各細分市場的潛在收入成長機會,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數創建了全球合成生物學市場主要公司的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球合成生物學市場報告的目標受群眾外包括產業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球合成生物學市場分析中使用的各種策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件

第2章 市場概覽

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • 市場機會藍圖

第3章主要見解

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • PEST分析
  • 波特的分析
  • 技術進步
  • 合併、收購和合作情景
  • 近期產品核可
  • 進出口分析
  • 監管趨勢
  • 價格分析
  • 生產能力
  • 銷售代理情況
  • 投資及資金籌措
  • 品牌地圖
  • 衝突簡介
  • 企業定位分析
  • 熱圖分析

第4章 全球合成生物學市場:依產品分類,2021-2033年

  • 寡核苷酸
  • 酵素
  • 合成細胞
  • 宿主生物
  • 其他

第5章 全球合成生物學市場:依技術分類,2021-2033年

  • 基因組工程
  • PCR技術
  • 生物製程技術
  • NGS技術
  • 生物資訊學
  • 奈米科技
  • 其他

第6章 全球合成生物學市場:依最終用戶分類,2021-2033年

  • 製藥公司
  • 生技公司
  • 首席行銷長和首席營收官
  • 其他

第7章 全球合成生物學市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • 參與企業的看法
  • 競爭對手儀錶板
  • 按公司分類的市佔率分析(2026 年)- 全球市場
  • 公司概況 - 全球合成生物學市場
  • Thermo Fisher Scientific
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs(UK)Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

第9章 機會分析

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI112

Synthetic Biology Market is estimated to be valued at USD 26.87 Bn in 2026 and is expected to reach USD 112.51 Bn by 2033, growing at a compound annual growth rate (CAGR) of 22.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 26.87 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 22.70% 2033 Value Projection: USD 112.51 Bn

Synthetic biology is an emerging field that applies engineering principles to biology. It involves the design and construction of novel artificial biological pathways, organisms or devices or the re-design of existing natural biological systems. Some key applications of synthetic biology include development of advanced biomanufacturing techniques for fuels, chemicals and materials as well as development of engineered organisms for agriculture, pharmaceuticals and environmental solutions. Researchers are working towards developing engineered biological systems for more effective and environment-friendly production processes. Advancements in DNA sequencing, gene assembly, and editing techniques have enabled rapid progress in the field with the potential to address many pressing global challenges in healthcare, energy, and environment.

Market Dynamics

The global synthetic biology market is driven by factors such as increasing R&D funding and investment in the field, advancements in DNA sequencing and gene editing technologies, rising demand for biopharmaceuticals, and development of techniques like metabolic engineering. Industry standards are being developed to ensure the responsible and safe application of synthetic biology. However, regulatory issues relating to genetically engineered organisms and ethical concerns could potentially restrain the market growth. Synthetic biology offers opportunities to address challenges in several sectors like drug discovery, industrial biomanufacturing, and environmental remediation. Development of commercial applications, international collaborations, and improved cost efficiencies in DNA synthesis and genome engineering will support market expansion.

Key Features of the Study

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global synthetic biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Thermo Fisher Scientific, Synbio Technologies, Merck KGaA, Agilent Technologies Inc., GenScript, Amyris, Eurofins Genomics GmbH, Integrated DNA Technologies Inc., Codexis Inc., EnBiotix Inc., Synthego, New England Biolabs (UK) Ltd., Scarab Genomics LLC , Genomatica Inc., Novonesis Group, Bota Bio, Creative Biogene, and Illumina, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global synthetic biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global synthetic biology market.

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2021 - 2033)
  • Oligonucleotides
  • Enzymes
  • Synthetic Cells
  • Chassis Organism
  • Others
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)
  • Genome Engineering
  • PCR Technology
  • Bioprocessing Technology
  • NGS Technology
  • Bioinformatics
  • Nanotechnology
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • CMO & CRO
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Thermo Fisher Scientific
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs (UK) Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals
  • Import-Export Analysis
  • Regulatory Scenario
  • Pricing Analysis
  • Manufacturing Capacities
  • Distributors Landscape
  • Investments & Funding
  • Brand Mapping
  • Competitive Snapshot
  • Company Positioning Analysis
  • Heat Map Analysis

4. Global Synthetic Biology Market, By Product, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033
    • Market Y-o-Y Growth Comparison (%), 2021 - 2033
    • Segment Trends
  • Oligonucleotides, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Enzymes, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Synthetic Cells, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Chassis Organism, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Others, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)

5. Global Synthetic Biology Market, By Technology, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033
    • Market Y-o-Y Growth Comparison (%), 2021 - 2033
    • Segment Trends
  • Genome Engineering, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • PCR Technology, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Bioprocessing Technology, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • NGS Technology, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Bioinformatics, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Nanotechnology , 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Others, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)

6. Global Synthetic Biology Market, By End User, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033
    • Market Y-o-Y Growth Comparison (%), 2021 - 2033
    • Segment Trends
  • Pharmaceutical Companies, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Biotechnology Companies, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • CMO & CRO, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)
  • Others, 2021 - 2033(USD Bn)
    • Introduction
    • Market Size and Forecast, 2021 - 2033, (USD Bn)

7. Global Synthetic Biology Market, By Region, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, (USD Bn)
    • Market Y-o-Y Growth Comparison (%), 2021 - 2033, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Asean
      • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2026 - Global
  • Company Profiles - Global Synthetic Biology Market
  • Thermo Fisher Scientific
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs (UK) Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

9. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact